CORCEPT THERAPEUTICS INC — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-07-14

Reporting Person: Hunt Hazel (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-14	Common Stock	M	50000	$2.89	Acquired	68975	Direct
2021-07-14	Common Stock	F	30482	$20.59	Disposed	38493	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-14	Stock Option (Right to Buy)	$2.89	M	50000	Disposed	2021-08-09	Common Stock (50000)	Direct

Footnotes

F1: These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on August 9, 2021.

F2: Fully exercisable.